Aim. This paper evaluates the effects of colloidal oatmeal (derived by Avena Sativa L.) derivates in daily use of some products for skin care on 300 children, during a randomized controlled trial. Methods. All the subjects recruited were randomly allocated to one of five groups. All children used the same product for three months. Results. After 3 months of treatment the cutaneous conditions improved according to the physicians in 201/263 children. Parents increased satisfaction level during the study as their judgement regarding the products was "very good" in 153/263 cases after 2 weeks of treatment and in 201/263 cases after 3 months. Conclusions. These results suggest that colloidal oatmeal products are indicated in daily use of children with mild dermatitis and are useful to cooperate with pharmacological products
The use of colloidal oatmeal products in the care of children with mild atopic dermatitis / Camplone G.; Arcangeli F.; Bonifazi E.; Gelmetti C.; Menni S.; Mulas P.; Paradisi M.; Patrizi A.. - In: PD. EUROPEAN JOURNAL OF PEDIATRIC DERMATOLOGY. - ISSN 1122-7672. - STAMPA. - 14:3(2004), pp. 157-160.
The use of colloidal oatmeal products in the care of children with mild atopic dermatitis
PATRIZI, ANNALISA
2004
Abstract
Aim. This paper evaluates the effects of colloidal oatmeal (derived by Avena Sativa L.) derivates in daily use of some products for skin care on 300 children, during a randomized controlled trial. Methods. All the subjects recruited were randomly allocated to one of five groups. All children used the same product for three months. Results. After 3 months of treatment the cutaneous conditions improved according to the physicians in 201/263 children. Parents increased satisfaction level during the study as their judgement regarding the products was "very good" in 153/263 cases after 2 weeks of treatment and in 201/263 cases after 3 months. Conclusions. These results suggest that colloidal oatmeal products are indicated in daily use of children with mild dermatitis and are useful to cooperate with pharmacological productsI documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
